Adello Biologics LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2012-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.adellobio.com
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Study Comparing TPI-120 and Neulasta Administered Through Subcutaneous Route in Healthy Adult Subjects
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2017-07-02
- Last Posted Date
- 2018-07-03
- Lead Sponsor
- Adello Biologics, LLC
- Target Recruit Count
- 120
- Registration Number
- NCT03206229
- Locations
- 🇺🇸
WCCT Global Inc., Cypress, California, United States
Comparative Immunogenicity Study Comparing TPI-120 to Neulasta® in Healthy Adult Subjects
- First Posted Date
- 2017-06-29
- Last Posted Date
- 2018-07-05
- Lead Sponsor
- Adello Biologics, LLC
- Target Recruit Count
- 102
- Registration Number
- NCT03202927
- Locations
- 🇺🇸
Celerion Inc., Lincoln, Nebraska, United States
News
No news found